Home › Mild Cognitive Impairment › NCT03094026
Cognitive Training Intervention and Attitudes Towards Genetics
Intervention Strategies to Improve Cognitive Functioning in Hematologic Cancer Survivors After Hematopoietic Cell Transplantation
Who can join
Ages 21 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * ≥ 21 years old at time of allogeneic HCT performed at UAB * Outpatient and between 3 and 6 months post HCT * English speaking * Possess access to an internet-connected home computer Exclusion criteria: * History of pre-existing neurological disorder or documented major psychiatric disorder; significant auditory, visual, or motor impairments * Participated in neuropsychological intervention within the past 6 months * History of color blindness
About the study
A pilot study to evaluate feasibility of enrollment of patients in an intervention to improve neurocognitive function in hematopoietic cell transplantation (HCT) survivors using the cognitive training Lumosity program. In addition, patients' interest in receiving information regarding genetic risk of cognitive impairment post-HCT will be measured.
What is being tested
- Lumosity (behavioral)
- Lumosity (waitlist control) (behavioral)
Sponsor: University of Alabama at Birmingham · Participants: 60 · Started: Aug 21, 2017
Contact the study team
- Noha M Sharafeldin, MD,MSc, PhD · Phone: 2056382144
- Lindsey Hageman, MPH · Phone: 2056382139
Official record on ClinicalTrials.gov — NCT03094026
Locations in the U.S.
| Alabama | University of Alabama at Birmingham, Birmingham |
Conditions
From ClinicalTrials.gov, data retrieved Oct 3, 2026. Each study sets its own eligibility; the study team decides who can join.